NEXTENSA NV/SA: SHARES – VOTING RIGHTS AND DENOMINATOR PUBLICATION IN COMPLIANCE WITH ART. 15 OF THE LAW OF 2 MAY 2007 (THE TRANSPARENCY ACT)
NEXTENSA NV/SA: SHARES – VOTING RIGHTS AND DENOMINATOR
PUBLICATION IN COMPLIANCE WITH ART. 15 OF THE LAW OF 2 MAY 2007 (THE TRANSPARENCY ACT)
As previously announced1, the EGM of 19 July 2021 introduced the double voting right (loyalty voting right), in accordance with article 7:53 of the Code of Companies and Associations.
This means, in accordance with article 28 of the articles of association, that double voting rights are granted to each fully paid-up share that has been continuously registered in the share register in the name of the same shareholder for at least two years. The other shares give right to one vote. The two-year period starts from the date of registration of the nominative shares in the share register.
In compliance with article 15 of the aforementioned Transparency Act, every month the Company must publish, on its website and by means of a press release, the total capital, the changes to the total number of voting securities and the total number of voting rights, insofar as these data have undergone a change in the preceding month.
Pursuant to a request to convert the registered shares into dematerialized shares in the course of the preceding month, the Company publishes the following information, being the total number of voting rights on 30 November 2021:
• Total number of voting securities: 10,002,102
• Total number of voting rights (= denominator): 11,800,1702
Shareholders can use this information to check whether they exceed or fall below the statutory or legal notification threshold of the total voting rights and whether there is therefore an obligation to notify this threshold exceedance.
ABOUT NEXTENSA NV/SA
Nextensa NV/SA (previously named Leasinvest Real Estate) is a mixed property investor and developer since 19 July 2021. The company’s investment portfolio, which is spread over the Grand Duchy of Luxembourg (45%), Belgium (42%) and Austria (13%), had a total value on 30/09/2021 of approximately €1.41 billion.
Nextensa is one of Luxembourg’s biggest property investors. The development portfolio is spread over the Tour & Taxis and Cloche d’Or sites, where mixed (residential and office) developments are ongoing and new sub-projects will be launched in the coming years. On 30/09/2021 the total book value of this development portfolio was approximately €0.3 billion.
The company is listed on Euronext Brussels and it has a market capitalisation of € 726.2 million (value on 29/11/2021).
FOR MORE INFORMATION:
Michel Van Geyte,
Chief Executive Officer
T: +32 3 238 98 77
1 See the press release of 19 July 2021
2 204 of the 1,798,068 shares in the Company that in principle give right to double voting rights are held by a subsidiary of the Company. The voting rights attached to these 204 shares are accordingly suspended.
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.)18.8.2022 08:30:00 CEST | Press release
SAMPO PLC STOCK EXCHANGE RELEASE 18 August 2022 at 9:30 am Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.) Sampo plc (business code 0142213-3) has received a disclosure under Chapter 9, Section 5 of the Securities Markets Act, according to which the voting rights attached to Sampo A shares (ISIN: FI009003305) owned directly or indirectly by BlackRock, Inc. (USA tax ID 32-0174421) and its funds decreased on 16 August 2022 below five (5) per cent of Sampo plc’s total voting rights. Sampo's share capital comprises 533,261,351 shares, of which 533,061,351 are A shares and 200,000 are B shares. Each A share entitles its holder to one (1) vote and each B share to five (5) votes. Thus, the total number of votes is 534,061,351. Total positions of BlackRock, Inc and its funds subject to the notification: % of shares and voting rights (total of A)% of shares and voting rights through financial instruments (total of B)Total of both in % (A+B)Resultin
Systemair's Interim Report for the first quarter will be presented on August 2518.8.2022 08:00:00 CEST | Press release
Press Release, 18 August 2022 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q1 for the financial year 2022/23 will be published at 13:00 CET on August 25, 2022. A telephone conference will be held at 13:30 CET on August 25, 2022. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference: Call 010-884 8016 alternative international call +44 20 3936 2999 and enter code 539199 minutes before start. The presentation will be published on group.systemair.com For further information contact: Roland Kasper, CEO, + 46 73 094 40 13 Anders Ulff, CFO, + 46 70 577 40 09 Systemair AB, SE-739 30 Skinnskatteberg, Sweden, +46 222 440 00, www.systemair.com Systemair in brief Systemair is a leading ventilation company with operations in 52 countries in Europe, North America, the Middle East, Asia, Australia and Africa. The Company had sales of SEK 9.6 billion in the 2021/22 financial year and today employs approximately 6,700
Ultimovacs Expands High Dose Cohort Size in TENDU Phase I Prostate Cancer Trial after Safety Review18.8.2022 08:00:00 CEST | Press release
The TENDU interim safety results from nine patients show no safety concernsTrial extended to enroll up to three additional patients at the highest dose levelTENDU designed to evaluate the Tetanus-Epitope Targeting (TET)-platform in patients with prostate cancer Oslo, 18August 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, has completed treatment of three patients at the highest dose cohort in the phase I TENDU trial without any safety concerns. Based on these results, the company plans to enroll up to three additional patients at the highest dose level. The Drug Safety Monitoring Board, a group of experts set up to monitor patient safety during a clinical trial, found no safety concerns in any of the three dose cohorts. A total of nine patients have now been treated; three at each dose level (40 mcg, 400 mcg and 960 mcg). Ultimovacs plans to enroll up to three additional patients at the highest dose level (960 mcg) pro
Systemairs rapport för det första kvartalet presenteras den 25 augusti18.8.2022 08:00:00 CEST | Pressemelding
Pressmeddelande 18 augusti 2022 Systemair ABs (NASDAQ OMX Stockholm: SYSR) delårsrapport Q1 för räkenskapsåret 2022/23 kommer att offentliggöras kl. 13:00 CET den 25 augusti 2022. En telefonkonferens arrangeras kl. 13:30 CET den 25 augusti 2022. Rapporten presenteras av Roland Kasper, CEO, samt Anders Ulff, CFO. För att delta i telefonkonferensen: Ring 010-884 8016 alt. internationellt +44 20 3936 2999 och uppge kod 539199 minuter före start. Presentationen publiceras på group.systemair.com För ytterligare information kontakta: Roland Kasper, CEO, + 46 73 094 40 13 Anders Ulff, CFO, + 46 70 577 40 09 Systemair AB, 739 30 Skinnskatteberg, 0222-440 00, www.systemair.com Systemair i korthet Systemair är ett ledande ventilationsföretag med verksamhet i 52 länder i Europa, Nordamerika, Mellanöstern, Asien, Australien och Afrika. Bolaget omsatte 9,6 miljarder kronor räkenskapsåret 2021/22 och har idag cirka 6 700 anställda. Sedan grundandet av Systemair 1974 har bolaget uppvisat positiva rör
Equinor ASA: Announcement of dividend per share in NOK for first quarter 202218.8.2022 07:50:00 CEST | Press release
Equinor (OSE: EQNR, NYSE: EQNR) announced on 4 May 2022 an ordinary dividend per share of USD 0.20 and an extraordinary dividend per share of USD 0.20 for first quarter 2022. The NOK dividend per share is based on average USDNOK fixing rate from Norges Bank in the period plus/minus three business days from record date 12 August 2022, in total seven business days. Average Norges Bank fixing rate for this period was 9.6405. Total cash dividend for first quarter 2022 of USD 0.40 per share is consequently NOK 3.8562 On 26 August 2022, dividend will be paid to shareholders on Oslo Børs (Oslo Stock Exchange) and to holders of American Depositary Receipts ("ADRs") on New York Stock Exchange. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.